Pillar VC reposted this
We are excited to announce that GRObio has closed $60M Series B financing, co-led by new investors, Atlas Venture and Access Industries with participation from previous investors, Leaps by Bayer, Redmile Group, Digitalis Ventures and Innovation Endeavors! The proceeds will be used to advance our lead program, ProGly-Uricase, into the clinic for the treatment of refractory #gout, to broaden the GRObio pipeline, and to expand our genomically recoded organism (GRO) platform for scalable production of therapeutics incorporating multiple non-standard amino acids (NSAAs). Thank you to all of our investors for supporting our mission to transform treatments in diverse areas including #autoimmune and #metabolic diseases to improve the lives of patients. See more on today’s news here: https://lnkd.in/eEsyUX3s.